|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ChiCTR |
|
Last refreshed on:
|
18 April 2017 |
|
Main ID: |
ChiCTR-IOR-14005316 |
|
Date of registration:
|
2014-07-23 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Influence of Dexmedetomidine on Incidence of Adverse Reactions Introduced by Hemabate in Postpartum Hemorrhage During Cesarean Section
|
|
Scientific title:
|
Influence of Dexmedetomidine on Incidence of Adverse Reactions Introduced by Hemabate in Postpartum |
|
Date of first enrolment:
|
2014-08-30 |
|
Target sample size:
|
Placebo:40;Lower dose:40;Higher dose:40; |
|
Recruitment status: |
Completed |
|
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=9634 |
|
Study type:
|
Interventional study |
|
Study design:
|
Randomized parallel controlled trial
|
|
Phase:
|
Other
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
WenHua Zhang
|
|
Address:
|
9 Jinsui Road, Guangzhou
|
|
Telephone:
|
+86 13611453199 |
|
Email:
|
849412396@qq.com |
|
Affiliation:
|
Guangzhou Women and Children's Medical Center |
|
|
Name:
|
Jin Ni
|
|
Address:
|
9 Jinsui Road, Guangzhou
|
|
Telephone:
|
+86 18902268256 |
|
Email:
|
drnijin@126.com |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: The inclusion criteria were 20-40 years of age, height 155-170cm and capable of comprehending oral and written Chinese.
Exclusion criteria: Exclusion criteria contained long-term opioid pain relieving utilization or NSAIDs, sedative utilization, mental illnesses, preoperative heart rate (HR) lower than 50bpm with atrial-ventricular conduction abnormalities or rhythm irregularities, neuromuscular and endocrine sicknesses or hypersensitive reactions to a2-adrenergic receptor agonists, or any past abdominal operation containing earlier caesarean delivery. Patients with coagulation issues or contraindications for receiving prostaglandin medications were additionally excluded from the study.
Age minimum:
18
Age maximum:
40
Gender:
Male
|
|
Health Condition(s) or Problem(s) studied
|
|
Cesarean Section
|
|
Intervention(s)
|
|
Placebo:intravenously physiological saline 20mL;Lower dose:lower dose (0.5ug kg-1) of dexmedetomidine;Higher dose:Higher dose (1ug kg-1) of dexmedetomidine;
|
|
Primary Outcome(s)
|
|
satisfaction score;
|
|
Source(s) of Monetary Support
|
|
Self-financing
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|